Angelini Farmacéutica
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study. (NCT04742413) | Angelini Farmacéutica | 2020-12-29 |
| N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS (NCT04122729) | Angelini Farmacéutica | 2019-09-25 |
| Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM) (NCT03435120) | Angelini Farmacéutica | 2017-12-21 |
Track Angelini Farmacéutica automatically
Every clearance here is in the API, with alerts when new ones post.